1. Home
  2. BON vs QNRX Comparison

BON vs QNRX Comparison

Compare BON & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bon Natural Life Limited

BON

Bon Natural Life Limited

N/A

Current Price

$1.32

Market Cap

10.6M

Sector

Health Care

ML Signal

N/A

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

HOLD

Current Price

$4.95

Market Cap

11.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BON
QNRX
Founded
2006
2018
Country
China
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
11.6M
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
BON
QNRX
Price
$1.32
$4.95
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
20.5K
29.0K
Earning Date
01-23-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$390.73
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.13
$4.11
52 Week High
$3.39
$41.80

Technical Indicators

Market Signals
Indicator
BON
QNRX
Relative Strength Index (RSI) 58.03 43.71
Support Level $1.32 $4.55
Resistance Level $1.33 $6.84
Average True Range (ATR) 0.06 0.46
MACD 0.01 0.02
Stochastic Oscillator 59.89 66.12

Price Performance

Historical Comparison
BON
QNRX

About BON Bon Natural Life Limited

Bon Natural Life Ltd focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by its customers. It has developed four technology platforms for large-scale separation, safety improvement, activity enhancement, and functional compounding of natural products. The company's offerings include Fragrance compounds, Health supplements, and Bioactive food ingredients. The company generates revenue from the sale of its products, the majority derived from the sale of Fragrance compounds, which include natural compounds extracted from plants for cosmetic applications.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: